We are live on ! Find out more
RHBC

R.H. Bluestein & Co Portfolio holdings

AUM $1.61B
1-Year Est. Return 7.59%
This Fund
S&P 500
This Quarter Est. Return
+5.56%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
AUM
$1.6B
AUM Growth
+$2.73M
Cap. Flow
-$57.6M
Cap. Flow %
-3.6%
Top 10 Hldgs %
27.48%
Holding
400
New
43
Increased
63
Reduced
145
Closed
50

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$20.3M
2
NEE icon
NextEra Energy
NEE
+$19.1M
3
DD icon
DuPont de Nemours
DD
+$14.5M
4
MMM icon
3M
MMM
+$13.4M
5
BUD icon
AB InBev
BUD
+$9.22M

Sector Composition

Rank Sector Weight
1 Industrials 22.78%
2 Healthcare 12.8%
3 Consumer Staples 10%
4 Consumer Discretionary 9.98%
5 Technology 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPS icon
26
United Parcel Service
UPS
$88.7B
$26.1M 1.63%
234,863
-117,781
-33% -$12.4M
NEE icon
27
NextEra Energy
NEE
$185B
$26.1M 1.63%
982,212
+755,192
+333% +$19.1M
OXY icon
28
Occidental Petroleum
OXY
$55.8B
$25.1M 1.57%
312,148
-46,349
-13% -$3.85M
SLB icon
29
SLB Ltd
SLB
$73.2B
$24.1M 1.51%
281,773
-13,225
-4% -$1.22M
AMZN icon
30
Amazon
AMZN
$2.49T
$23.8M 1.49%
1,535,620
-1,820
-0.1% -$28.4K
PANW icon
31
Palo Alto Networks
PANW
$257B
$23.6M 1.48%
1,154,904
-5,970
-0.5% -$110K
JNJ icon
32
Johnson & Johnson
JNJ
$642B
$22.1M 1.38%
211,487
+192,982
+1,043% +$20.3M
GILD icon
33
Gilead Sciences
GILD
$167B
$21.7M 1.36%
230,684
-17,342
-7% -$1.79M
BA icon
34
Boeing
BA
$170B
$20.8M 1.3%
160,252
-34,681
-18% -$4.4M
GLOG
35
DELISTED
GASLOG LTD
GLOG
$19.6M 1.23%
963,388
+463,513
+93% +$9.09M
BMY icon
36
Bristol-Myers Squibb
BMY
$130B
$19.4M 1.21%
328,764
-6,549
-2% -$369K
UAA icon
37
Under Armour
UAA
$3.03B
$18.7M 1.17%
556,051
+113,079
+26% +$3.78M
AXP icon
38
American Express
AXP
$225B
$16.3M 1.02%
174,723
-3,143
-2% -$282K
XYL icon
39
Xylem
XYL
$28.4B
$16.1M 1.01%
422,079
-48
-0% -$1.76K
ARMH
40
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$15.9M 0.99%
342,861
-111,018
-24% -$4.74M
GT icon
41
Goodyear
GT
$2.1B
$15.5M 0.97%
543,136
-257,281
-32% -$6.37M
NLSN
42
DELISTED
Nielsen Holdings plc
NLSN
$15.2M 0.95%
339,202
+127,227
+60% +$5.45M
MMM icon
43
3M
MMM
$92.4B
$14.8M 0.92%
107,520
+104,111
+3,054% +$13.4M
DAL icon
44
Delta Air Lines
DAL
$57.5B
$14.7M 0.92%
299,010
-220,610
-42% -$9.29M
META icon
45
Meta Platforms (Facebook)
META
$1.51T
$14.6M 0.91%
187,180
-11,441
-6% -$875K
DD icon
46
DuPont de Nemours
DD
$18.7B
$14.3M 0.9%
124,239
+118,711
+2,147% +$14.5M
IBM icon
47
IBM
IBM
$216B
$12.9M 0.81%
84,072
+9,089
+12% +$1.45M
BABA icon
48
Alibaba
BABA
$279B
$11.2M 0.7%
108,165
+56,165
+108% +$5.76M
GPRO icon
49
GoPro
GPRO
$122M
$11.1M 0.69%
175,602
-117,860
-40% -$8.69M
AXON
50
Axon Enterprise
AXON
$44B
$10.2M 0.64%
+385,499
New +$7.6M

Similar funds

R.H. Bluestein & Co's Q4 2014 Portfolio in Review

As of Q4 2014, R.H. Bluestein & Co held 400 positions worth $1.6B, up 0.17% from $1.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

R.H. Bluestein & Co withdrew a net $57.6M in Q4 2014, closing 50 positions and reducing 145 holdings. Its most notable exit was Whiting Petroleum Corporation, an estimated $33.7M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, R.H. Bluestein & Co opened a new position in Axon Enterprise worth $10.2M.

  • R.H. Bluestein & Co's largest Q4 2014 buy was Axon Enterprise: 385,499 shares worth $10.2M.
  • R.H. Bluestein & Co added most to Johnson & Johnson in Q4 2014, an estimated $20.3M increase.
  • R.H. Bluestein & Co's biggest Q4 2014 reduction was Perrigo, cutting an estimated $25.8M.
  • R.H. Bluestein & Co fully exited Whiting Petroleum Corporation in Q4 2014, selling an estimated $33.7M.
  • R.H. Bluestein & Co's ten largest holdings make up 27% of its $1.6B portfolio in Q4 2014.
  • R.H. Bluestein & Co opened 43 new positions and closed 50 in Q4 2014.
  • R.H. Bluestein & Co's portfolio value rose 0.17% quarter-over-quarter to $1.6B.

Based on R.H. Bluestein & Co's 13F filing for Q4 2014, filed 12 Feb 2015.